Chronic Inflammatory Disease Biotech Evommune Files for a $100 Million IPO
California-based biotechnology company Evommune Inc. has filed for an initial public offering (IPO) worth up to $100 million, marking a major step in its...
Turn Therapeutics to Direct List on Nasdaq, Bringing Innovative Wound and Skin Treatments to Public Markets
Turn Therapeutics, a biotechnology company specializing in wound care and dermatology, is set to begin trading on the Nasdaq today (October 8) through a...
Molecular diagnostics company BillionToOne files for a $100 million IPO
Molecular diagnostics company BillionToOne Inc. has filed for an initial public offering (IPO) in the United States, seeking to raise up to $100 million...
Autonomous Lawn Care Equipment Manufacturer Firefly Automatix Files for a $25 Million IPO
Firefly Automatix Inc., a U.S.-based manufacturer of autonomous lawn care and turf maintenance equipment, has filed to raise up to $25 million through an...
SPAC Lake Superior Acquisition Prices $100 Million IPO
Lake Superior Acquisition Corp, a newly formed special purpose acquisition company (SPAC), has priced its $100 million initial public offering as it seeks to...